FI862493A - Fysiologiska medel foer effektivering av transdermal administration av laekemedel. - Google Patents

Fysiologiska medel foer effektivering av transdermal administration av laekemedel. Download PDF

Info

Publication number
FI862493A
FI862493A FI862493A FI862493A FI862493A FI 862493 A FI862493 A FI 862493A FI 862493 A FI862493 A FI 862493A FI 862493 A FI862493 A FI 862493A FI 862493 A FI862493 A FI 862493A
Authority
FI
Finland
Prior art keywords
laekemedel
medel
physiological
effectiveness
transdermal administration
Prior art date
Application number
FI862493A
Other languages
English (en)
Finnish (fi)
Other versions
FI862493A0 (fi
Inventor
Nicholas Bodor
Original Assignee
Key Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Key Pharma filed Critical Key Pharma
Publication of FI862493A0 publication Critical patent/FI862493A0/fi
Publication of FI862493A publication Critical patent/FI862493A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI862493A 1984-10-11 1986-06-11 Fysiologiska medel foer effektivering av transdermal administration av laekemedel. FI862493A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65991984A 1984-10-11 1984-10-11
PCT/US1985/001951 WO1986002272A1 (en) 1984-10-11 1985-10-09 Physiological means of enhancing transdermal delivery of drugs

Publications (2)

Publication Number Publication Date
FI862493A0 FI862493A0 (fi) 1986-06-11
FI862493A true FI862493A (fi) 1986-06-11

Family

ID=24647370

Family Applications (1)

Application Number Title Priority Date Filing Date
FI862493A FI862493A (fi) 1984-10-11 1986-06-11 Fysiologiska medel foer effektivering av transdermal administration av laekemedel.

Country Status (15)

Country Link
EP (1) EP0198034B1 (id)
JP (1) JPS62500523A (id)
KR (1) KR930009787B1 (id)
AU (1) AU592322B2 (id)
CA (1) CA1264033A (id)
DE (1) DE3583234D1 (id)
DK (1) DK269986A (id)
FI (1) FI862493A (id)
GR (1) GR852469B (id)
IE (1) IE59291B1 (id)
IL (1) IL76635A0 (id)
MY (1) MY100471A (id)
NO (1) NO862321L (id)
NZ (1) NZ213753A (id)
WO (1) WO1986002272A1 (id)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1705319A1 (ru) * 1987-10-23 1992-01-15 Всесоюзный Научно-Исследовательский Институт Биотехнологии Состав полимерной диффузионной матрицы дл трансдермального введени лекарственных веществ
US6395757B1 (en) * 1998-08-31 2002-05-28 Arthur M. Bobrove Method for treating hot flashes in humans
CA2461696A1 (en) * 2001-09-26 2003-04-03 Alison B. Lukacsko Compositions and methods for inhibiting eccrine perspiration in humans
WO2006069998A2 (de) * 2004-12-27 2006-07-06 Beiersdorf Ag Glycopyrrolat in kosmetischen zubereitungen
KR20150119468A (ko) 2013-02-28 2015-10-23 더미라, 인코포레이티드 글리코피롤레이트 염
US9006462B2 (en) 2013-02-28 2015-04-14 Dermira, Inc. Glycopyrrolate salts

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US376886A (en) * 1888-01-24 Joseph beeakley holder
US3767786A (en) * 1961-04-20 1973-10-23 Procter & Gamble Inhibiting perspiration with scopolamine esters
US4031894A (en) * 1975-12-08 1977-06-28 Alza Corporation Bandage for transdermally administering scopolamine to prevent nausea
NL8104929A (nl) * 1980-11-12 1982-06-01 Alza Corp Anticholinergische preparaten, alsmede de bereiding en de toepassing ervan.
US4379454A (en) * 1981-02-17 1983-04-12 Alza Corporation Dosage for coadministering drug and percutaneous absorption enhancer

Also Published As

Publication number Publication date
DE3583234D1 (de) 1991-07-18
GR852469B (id) 1986-02-12
MY100471A (en) 1990-10-15
NZ213753A (en) 1988-09-29
AU4968585A (en) 1986-05-02
DK269986A (da) 1986-08-11
IL76635A0 (en) 1986-02-28
FI862493A0 (fi) 1986-06-11
EP0198034B1 (en) 1991-06-12
NO862321L (no) 1986-08-07
JPS62500523A (ja) 1987-03-05
DK269986D0 (da) 1986-06-09
AU592322B2 (en) 1990-01-11
NO862321D0 (no) 1986-06-10
CA1264033A (en) 1989-12-27
WO1986002272A1 (en) 1986-04-24
KR930009787B1 (ko) 1993-10-11
IE852491L (en) 1986-04-11
EP0198034A1 (en) 1986-10-22
IE59291B1 (en) 1994-02-09
KR870700364A (ko) 1987-12-28

Similar Documents

Publication Publication Date Title
NO864126D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyridon-derivater.
FI862094A (fi) Bornerande terapeutisk komposition.
FI872626A0 (fi) Anordning foer foerdroejd transdermal frisaettning av laekemedel.
NO864879L (no) Fremgangsmaate for fremstilling av terapeutisk aktive tiazolforbindelser.
NO864674D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive cefemforbindelser.
NO862373D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tienopyridoner.
NO874824D0 (no) Bruker-aktivert transdermalt terapeutisk system.
DE3669105D1 (de) Therapeutische zusammensetzung.
NO885598L (no) Fremgangsmaate for fremstilling av terapeutisk aktive ammoniumforbindelser.
FI823217L (fi) Aminopropanolderivat av 2-hydroxi- -fenylpropiofenoner, foerfaranden foer deras framstaellning ochdessa innehaollande terapeutiska medel
NO164897C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive oxazolidinonderivater.
FI850193A0 (fi) Terapeutiska lhrh analoger.
NO862372D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater.
FI860209A (fi) Engaongselektrod foer undersoekning av en patient.
NO870533L (no) Terapeutisk aktive 3-alkoksy-2-aminopropylaminer.
NO861584L (no) Fremgangsmaate til fremstilling av terapeutisk aktive cyklopentyletere.
NO884176D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive amidinoderivater.
NO164899C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazolylindolforbindelser.
FI862493A0 (fi) Fysiologiska medel foer effektivering av transdermal administration av laekemedel.
NO873835D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive karbocykliske pyridiner.
NO864101D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive dikloranilinderivater.
NO162188C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazokinoliner.
NO862390D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,4-dihydropyridinderivater.
NO162072C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tienopyridinderivater.
NO165542C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-aryl-2,4-dialkyl-3h-1,2,4-triazol-3-thioner.

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: KEY PHARMACEUTICALS, INC.